Palatin Technologies, Inc. (NYSE American:PTN)

About the company

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Sector

Health Technology

Industry

Biotechnology

Employees

18

CEO

Carl Spana

Exchange

NYSE American

Website

http://www.palatin.com

$60.00M

Total Revenue

18

Employees

$121.38M

Market Capitalization

2.83

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$60M

Operating Margin (in %)

Total operating margin

$36M

Net Margin (in %)

Total net margin

$37M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Cyclacel Pharmaceuticals, Inc. CYCCP None 0.00 None None -748.10
Amgen, Inc. AMGN 152107.09 23966.00 15.70 19.82 32.02
Gilead Sciences, Inc. GILD 98340.06 22716.00 4.39 19.79 21.84
Vertex Pharmaceuticals, Inc. VRTX 76983.46 4819.00 11.79 50.92 31.35
Regeneron Pharmaceuticals, Inc. REGN 73741.45 8319.00 5.42 32.22 27.40
Illumina, Inc. ILMN 55000.37 3556.00 11.71 58.22 26.49
Biogen, Inc. BIIB 50909.87 14422.00 3.66 8.69 40.76
Seattle Genetics, Inc. SGEN 29136.24 956.00 17.00 -93.24 -32.82
Agilent Technologies, Inc. A 28027.64 5236.00 5.78 40.76 13.04
Moderna, Inc. MRNA 25288.48 53.00 16.98 -50.03 -961.85
Alexion Pharmaceuticals, Inc. ALXN 24319.68 5296.00 2.04 10.25 44.83
BioMarin Pharmaceutical, Inc. BMRN 22883.83 1805.00 7.06 200.68 6.31
Incyte Corp. INCY 21701.90 2229.00 11.17 -56.89 -16.87
Alnylam Pharmaceuticals, Inc. ALNY 17452.53 286.00 13.37 -19.65 -310.01
Neurocrine Biosciences, Inc. NBIX 12718.64 887.00 17.39 69.01 19.90
EXACT Sciences Corp. EXAS 12293.01 1062.00 5.30 -130.04 -10.05
Sarepta Therapeutics, Inc. SRPT 12148.50 407.00 11.03 -18.26 -160.96
Bio-Techne Corp. TECH 10400.13 755.00 7.89 56.14 24.76
Ionis Pharmaceuticals, Inc. IONS 8733.00 959.00 6.30 55.41 17.09
10X Genomics, Inc. TXG 8713.18 264.00 21.37 -177.82 -18.45
ACADIA Pharmaceuticals, Inc. ACAD 8058.00 366.00 13.10 -34.00 -64.99
Immunomedics, Inc. IMMU 7954.03 0.00 49.35 -21.96 -849.13
Exelixis, Inc. EXEL 7497.00 979.00 4.18 25.59 30.01
CRISPR Therapeutics AG CRSP 5363.69 289.00 7.05 95.69 15.73
Vir Biotechnology, Inc. VIR 5354.64 10.00 16.47 -24.07 None
Acceleron Pharma, Inc. XLRN 5214.14 76.00 14.14 -37.98 -182.30
Emergent BioSolutions, Inc. EBS 5122.98 1108.00 4.72 73.79 6.14
Ultragenyx Pharmaceutical, Inc. RARE 4888.82 122.00 8.26 -11.47 -348.78
Mirati Therapeutics, Inc. MRTX 4691.31 2.00 8.00 -18.39 -761.40
Arrowhead Pharmaceuticals, Inc. ARWR 4613.00 139.00 9.49 512.56 6.86
Allogene Therapeutics, Inc. ALLO 4269.20 None 9.39 -20.42 None
China Biologic Products Holdings, Inc. CBPO 4183.92 537.00 2.38 27.16 28.48
TESARO, Inc. TSRO 4122.80 219.00 -31.50 -6.32 -295.67
Global Blood Therapeutics, Inc. GBT 4061.56 16.00 8.01 -14.05 None
Halozyme Therapeutics, Inc. HALO 4028.54 164.00 65.98 -51.58 -48.75
Blueprint Medicines Corp. BPMC 3832.50 72.00 6.08 -10.36 -515.98
Amicus Therapeutics, Inc. FOLD 3775.04 209.00 9.64 -11.84 -155.73
FibroGen, Inc. FGEN 3659.22 257.00 8.18 -33.65 -42.75
Momenta Pharmaceuticals, Inc. MNTA 3566.16 29.00 9.42 -12.25 -994.16
Iovance Biotherapeutics, Inc. IOVA 3536.25 None 17.04 -15.38 None
ChemoCentryx, Inc. CCXI 3457.40 33.00 65.84 -53.27 -194.82
Arena Pharmaceuticals, Inc. ARNA 3425.16 6.00 3.85 -10.27 49.30
bluebird bio, Inc. BLUE 3312.65 45.00 2.61 -4.21 -947.42
Novavax, Inc. NVAX 3299.10 18.00 -268.22 -27.63 -638.76
PTC Therapeutics, Inc. PTCT 3267.60 322.00 6.76 -11.37 -90.83
Agios Pharmaceuticals, Inc. AGIO 3201.03 175.00 5.60 -8.67 -205.20
bluebird bio, Inc. BLUE 3127.30 54.00 2.82 -3.80 -947.42
Alkermes Plc ALKS 2989.28 1194.00 2.84 -21.89 -11.63
Audentes Therapeutics, Inc. BOLD 2638.68 None 7.17 -15.11 None
Deciphera Pharmaceuticals, Inc. DCPH 2549.28 25.00 4.51 -11.82 -868.56
Deciphera Pharmaceuticals, Inc. DCPH 2549.28 25.00 4.51 -11.82 -868.56
Denali Therapeutics, Inc. DNLI 2406.57 26.00 4.81 -11.23 -825.96
Fate Therapeutics, Inc. FATE 2357.91 11.00 13.13 -21.02 -919.00
Insmed, Inc. INSM 2335.52 151.00 12.95 -9.51 -162.82
Ligand Pharmaceuticals, Inc. LGND 2268.98 110.00 2.90 -128.41 -55.63
TG Therapeutics, Inc. TGTX 2130.98 0.00 -2267.00 -11.28 None
Viela Bio, Inc. VIE 2081.31 50.00 6.58 -19.62 -212.46
Kodiak Sciences, Inc. KOD 1950.80 None 6.62 -30.87 None
Xencor, Inc. XNCR 1857.16 77.00 3.08 -29.65 -79.39
uniQure NV QURE 1827.42 6.00 6.53 -14.50 -738.25
Twist Bioscience Corp. TWST 1761.21 66.00 8.98 -12.27 -222.66
Eidos Therapeutics, Inc. EIDX 1731.97 27.00 10.31 -35.73 -183.31
Dicerna Pharmaceuticals, Inc. DRNA 1622.60 55.00 9.62 -13.72 -213.04
Editas Medicine, Inc. EDIT 1612.62 24.00 8.37 -11.42 -588.05
Alector, Inc. ALEC 1552.50 23.00 4.54 -12.36 -556.70
Myovant Sciences Ltd. MYOV 1541.98 None -14.94 -5.32 None
Luminex Corp. LMNX 1479.28 343.00 3.33 -224.13 -1.76
Akebia Therapeutics, Inc. AKBA 1441.11 351.00 4.30 -5.39 -76.39
REGENXBIO, Inc. RGNX 1430.05 52.00 3.43 -13.95 -197.22
Cytokinetics, Inc. CYTK 1417.18 22.00 -31.19 -10.77 -592.61
Veracyte, Inc. VCYT 1396.32 122.00 6.32 -63.24 -18.36
Heron Therapeutics, Inc. HRTX 1394.00 140.00 4.07 -7.22 -138.31
Epizyme, Inc. EPZM 1390.26 17.00 4.91 -7.21 -727.88
MacroGenics, Inc. MGNX 1388.66 68.00 7.30 -9.20 -222.14
Zentalis Pharmaceuticals, Inc. ZNTL 1375.50 0.00 -14.72 -24.11 None
Intra-Cellular Therapies, Inc. ITCI 1370.54 1.00 3.65 -8.50 -981.67
NantKwest, Inc. NK 1338.48 0.00 14.08 -20.18 -969.27
Coherus BioSciences, Inc. CHRS 1331.25 435.00 8.00 8.88 33.42
Esperion Therapeutics, Inc. ESPR 1280.34 5.00 -26.05 -4.89 -65.49
NGM Biopharmaceuticals, Inc. NGM 1250.52 102.00 3.93 -18.39 -52.41
Sorrento Therapeutics, Inc. SRNE 1238.64 33.00 16.54 -4.34 -754.90
Karyopharm Therapeutics, Inc. KPTI 1235.84 59.00 8.51 -6.64 -316.53
Adverum Biotechnologies, Inc. ADVM 1234.14 0.00 4.86 -16.90 None
Beam Therapeutics, Inc. BEAM 1229.41 0.00 4.94 -11.62 None
NanoString Technologies, Inc. NSTG 1216.44 124.00 9.44 -22.08 -46.13
Cortexyme, Inc. CRTX 1202.92 None 5.60 -25.14 None
Sangamo Therapeutics, Inc. SGMO 1190.16 107.00 3.66 -12.67 -89.31
Rocket Pharmaceuticals, Inc. RCKT 1188.30 None 4.49 -14.56 None
Arvinas, Inc. ARVN 1162.70 45.00 6.14 -14.90 -171.74
Black Diamond Therapeutics, Inc. BDTX 1095.84 None 3.08 -25.16 None
Intellia Therapeutics, Inc. NTLA 1091.72 46.00 5.28 -9.90 -239.98
Enanta Pharmaceuticals, Inc. ENTA 1085.07 176.00 2.13 45.73 13.46
Arcus Biosciences, Inc. RCUS 1029.16 15.00 7.67 -10.88 -631.95
Mersana Therapeutics, Inc. MRSN 1020.00 1.00 22.85 -12.35 -66.97
Translate Bio, Inc. TBIO 1017.50 11.00 8.15 -10.88 -859.22
Aimmune Therapeutics, Inc. AIMT 1004.85 1.00 4.43 -3.59 None
Passage Bio, Inc. PASG 1001.70 None 2.61 -18.25 None
Meridian Bioscience, Inc. VIVO 988.14 204.00 4.81 46.90 10.47
BioXcel Therapeutics, Inc. BTAI 883.49 None 14.48 -22.11 None
Retrophin, Inc. RTRX 853.55 184.00 3.80 -8.10 -57.01
Myriad Genetics, Inc. MYGN 853.22 760.00 0.89 -5.76 -19.49
Rhythm Pharmaceuticals, Inc. RYTM 841.62 None 3.76 -5.68 None
Replimune Group, Inc. REPL 773.84 None 4.99 -14.78 None
CARA Therapeutics, Inc. CARA 771.76 24.00 5.11 -6.88 -480.29
Stoke Therapeutics, Inc. STOK 767.25 None 3.60 -20.39 None
Kura Oncology, Inc. KURA 765.60 None 4.79 -11.15 None
Atara Biotherapeutics, Inc. ATRA 744.15 None 3.96 -2.49 None
Morphic Holding, Inc. MORF 742.20 17.00 5.92 -13.67 -332.51
Sinovac Biotech Ltd. SVA 737.58 225.00 1.82 19.61 13.90
Rapt Therapeutics, Inc. RAPT 730.08 1.00 5.62 -15.76 None
Dynavax Technologies Corp. DVAX 707.63 40.00 83.55 -5.13 -319.06
Precigen, Inc. PGEN 700.44 98.00 8.80 -2.20 -324.18
XBiotech, Inc. XBIT 696.44 13.00 1.26 1.04 None
Rigel Pharmaceuticals, Inc. RIGL 693.00 102.00 8.78 -25.78 -27.39
Omeros Corp. OMER 677.79 114.00 -5.49 -7.64 -78.52
Frequency Therapeutics, Inc. FREQ 674.56 36.00 4.09 -35.67 -52.16
ImmunoGen, Inc. IMGN 657.14 87.00 -214.75 -7.54 -102.87
Vanda Pharmaceuticals, Inc. VNDA 649.55 237.00 1.55 5.54 49.12
VBI Vaccines, Inc. VBIV 631.40 2.00 14.09 -12.53 None
BioCryst Pharmaceuticals, Inc. BCRX 628.65 48.00 247.50 -5.50 -241.66
Homology Medicines, Inc. FIXX 613.36 2.00 2.78 -5.34 None
Radius Health, Inc. RDUS 608.58 191.00 -8.27 -4.79 -66.82
Pacific Biosciences of California, Inc. PACB 600.60 90.00 10.00 -11.47 -58.35
Vaxart, Inc. VXRT 593.95 7.00 51.42 -24.24 -252.86
ZIOPHARM Oncology, Inc. ZIOP 590.96 0.00 3.95 -4.68 None
Kadmon Holdings, Inc. KDMN 574.00 12.00 6.83 -5.94 -831.11
AnaptysBio, Inc. ANAB 559.17 23.00 1.41 -6.72 -363.13
Stemline Therapeutics, Inc. STML 532.35 47.00 4.21 -7.63 -150.30
Syros Pharmaceuticals, Inc. SYRS 522.45 4.00 7.23 -6.83 None
Cue Biopharma, Inc. CUE 512.16 4.00 13.42 -13.34 -959.05
Avrobio, Inc. AVRO 504.90 None 2.36 -6.21 None
Prothena Corp. Plc PRTA 502.00 1.00 1.96 -6.21 -556.84
Agenus, Inc. AGEN 501.79 85.00 -3.14 -2.89 -200.56
Flexion Therapeutics, Inc. FLXN 498.56 83.00 -9.65 -3.46 -175.76
Personalis, Inc. PSNL 497.60 70.00 4.97 -17.09 -40.60
Syros Pharmaceuticals, Inc. SYRS 497.51 4.00 6.89 -6.50 None
Viking Therapeutics, Inc. VKTX 493.20 1707.00 1.85 -16.31 8.92
UroGen Pharma Ltd. URGN 489.51 0.00 3.40 -4.02 -255.27
Molecular Templates, Inc. MTEM 488.40 19.00 6.67 -5.63 -439.47
Prevail Therapeutics, Inc. PRVL 485.18 None 3.29 -6.80 None
CEL-SCI Corp. CVM 485.10 0.00 43.31 -14.74 None
Corbus Pharmaceuticals Holdings, Inc. CRBP 477.18 36.00 23.32 -6.46 -207.87
Voyager Therapeutics, Inc. VYGR 474.34 117.00 5.99 -12.09 -34.70
Rubius Therapeutics, Inc. RUBY 472.42 None 2.05 -2.65 None
Syndax Pharmaceuticals, Inc. SNDX 460.48 2.00 9.72 -7.70 None
Athersys, Inc. ATHX 439.92 4.00 28.20 -9.40 -791.44
Ardelyx, Inc. ARDX 438.78 6.00 3.29 -4.75 -153.19
MeiraGTx Holdings Plc MGTX 429.10 17.00 2.48 -8.40 -313.73
Scholar Rock Holding Corp. SRRK 424.56 22.00 4.44 -7.28 -255.69
Protagonist Therapeutics, Inc. PTGX 420.93 2.00 8.86 -5.00 -125.87
MiMedx Group, Inc. MDXG 401.74 359.00 8.42 -13.54 -8.35
Precision BioSciences, Inc. DTIL 396.78 24.00 3.50 -10.51 -369.86
Puma Biotechnology, Inc. PBYI 395.07 224.00 42.21 -4.78 -36.74
CytomX Therapeutics, Inc. CTMX 393.30 78.00 5.63 -5.06 -97.82
Geron Corp. GERN 388.00 0.00 5.13 -5.13 -479.34
Avid Bioservices, Inc. CDMO 385.28 60.00 9.30 -25.48 -25.38
Pliant Therapeutics, Inc. PLRX 384.20 86.00 4.46 19.82 29.96
Clovis Oncology, Inc. CLVS 375.83 152.00 -4.42 -0.89 -271.12
Vermillion, Inc. VRML 368.00 5.00 80.00 -23.53 -307.31
Merus NV MRUS 367.64 29.00 3.58 -5.48 -225.72
Neoleukin Therapeutics, Inc. NLTX 366.96 25.00 3.12 -4.18 -126.34
Harpoon Therapeutics, Inc. HARP 361.44 8.00 4.52 -7.00 -680.88
Progenics Pharmaceuticals, Inc. PGNX 352.60 37.00 11.71 -5.32 -180.28
Spectrum Pharmaceuticals, Inc. SPPI 350.76 109.00 2.39 -2.63 -109.77
Unity Biotechnology, Inc. UBX 343.35 1.00 3.57 -3.76 None
Xenon Pharmaceuticals, Inc. XENE 336.84 14.00 2.34 -8.98 -261.58
Aptose Biosciences, Inc. APTO 335.12 0.00 4.98 -10.72 None
Wave Life Sciences Ltd. WVE 328.10 17.00 16.64 -1.68 None
PDL BioPharma, Inc. PDLI 323.51 54.00 0.57 -3.07 -201.30
MannKind Corp. MNKD 317.14 62.00 -1.69 -6.83 -74.96
Aspira Women's Health, Inc. AWH 315.56 5.00 68.60 -20.18 -307.31
Co-Diagnostics, Inc. CODX 314.46 2.00 24.96 -54.59 -334.77
Brainstorm Cell Therapeutics, Inc. BCLI 310.32 None 41.71 -11.34 None
Magenta Therapeutics, Inc. MGTA 292.11 None 2.88 -3.50 None
Cellular Biomedicine Group, Inc. CBMG 289.37 0.00 6.54 -5.60 -776.23
Immune Design Corp. IMDZ 280.80 2.00 3.08 -5.13 -720.81
Calithera Biosciences, Inc. CALA 275.40 22.00 2.82 -3.05 -245.48
Seres Therapeutics, Inc. MCRB 264.32 35.00 -4.86 -4.44 -186.09
Cabaletta Bio, Inc. CABA 263.28 None 2.00 -12.61 None
Pfenex, Inc. PFNX 260.04 43.00 3.24 -87.56 -7.03
Concert Pharmaceuticals, Inc. CNCE 255.50 0.00 1.96 -3.34 -533.31
Anavex Life Sciences Corp. AVXL 240.30 None 10.85 -9.27 None
Equillium, Inc. EQ 237.66 None 6.79 -8.85 None
MediciNova, Inc. MNOV 234.52 6.00 3.21 -21.32 -67.11
CymaBay Therapeutics, Inc. CBAY 229.77 10.00 1.31 -2.47 -275.57
Lexicon Pharmaceuticals, Inc. LXRX 229.32 321.00 3.84 2.65 26.59
NextCure, Inc. NXTC 228.20 27.00 0.68 -12.54 -65.22
Dyadic International, Inc. DYAI 225.99 2.00 6.70 -27.00 -523.67
Eiger BioPharmaceuticals, Inc. EIGR 222.96 None 5.40 -3.32 None
Aduro BioTech, Inc. ADRO 216.80 27.00 3.66 -3.27 -243.93
Five Prime Therapeutics, Inc. FPRX 204.75 18.00 1.59 -1.69 -679.63
CASI Pharmaceuticals, Inc. CASI 203.70 8.00 3.00 -4.37 -614.25
IVERIC bio, Inc. ISEE 198.45 210.00 3.74 -3.22 54.39
Strongbridge Biopharma Plc SBBP 182.05 24.00 2.93 -3.31 -181.82
Jounce Therapeutics, Inc. JNCE 179.20 137.00 1.14 4.06 31.23
Chimerix, Inc. CMRX 174.58 11.00 1.85 -1.63 -923.39
INmune Bio, Inc. INMB 173.25 None 7.61 -21.28 None
ADMA Biologics, Inc. ADMA 172.63 36.00 2.53 -3.25 -151.18
GlycoMimetics, Inc. GLYC 172.43 9.00 1.18 -3.37 -571.90
Alpine Immune Sciences, Inc. ALPN 172.14 3.00 6.76 -4.82 -449.62
Fennec Pharmaceuticals, Inc. FENC 169.60 None 25.70 -12.11 None
Paratek Pharmaceuticals, Inc. PRTK 165.20 23.00 -3.69 -1.35 -528.28
Chiasma, Inc. CHMA 162.24 13.00 2.45 -3.92 -22.14
Trevena, Inc. TRVN 159.80 0.00 6.30 -6.30 -537.06
Aldeyra Therapeutics, Inc. ALDX 159.60 None 3.90 -2.85 None
XOMA Corp. XOMA 159.48 11.00 4.75 -18.85 -78.07
Fortress Biotech, Inc. FBIO 156.60 43.00 6.00 -2.84 -124.73
Pieris Pharmaceuticals, Inc. PIRS 152.36 51.00 3.08 -6.81 -42.26
Galectin Therapeutics, Inc. GALT 151.25 None 3.87 -11.00 None
Surface Oncology, Inc. SURF 150.22 40.00 1.80 -4.80 -70.90
Dermira, Inc. DERM 150.00 11.00 29.30 -13.30 -102.68
Selecta Biosciences, Inc. SELB 146.40 7.00 -24.40 -2.18 -943.39
Aravive, Inc. ARAV 138.19 3.00 2.88 -5.68 -796.01
Pluristem Therapeutics, Inc. PSTI 134.40 0.00 14.74 -4.67 -816.51
Evofem Biosciences, Inc. EVFM 132.48 0.00 288.00 -1.67 None
X4 Pharmaceuticals, Inc. XFOR 129.92 3.00 1.10 5.49 None
Minerva Neurosciences, Inc. NERV 128.70 None 7.02 -1.89 None
Harvard Bioscience, Inc. HBIO 128.06 112.00 1.70 -18.72 -6.11
Enzo Biochem, Inc. ENZ 127.20 77.00 2.04 -4.08 -39.50
Solid Biosciences, Inc. SLDB 125.84 None 2.33 -1.09 None
Otonomy, Inc. OTIC 124.16 1.00 6.46 -2.78 None
Champions Oncology, Inc. CSBR 123.20 31.00 33.85 -880.00 -0.58
Matinas BioPharma Holdings, Inc. MTNB 122.98 0.00 2.03 -6.25 None
Palatin Technologies, Inc. PTN 121.38 60.00 1.34 2.83 61.44
Verastem, Inc. VSTM 116.20 21.00 1.84 -0.77 -715.40
La Jolla Pharmaceutical Co. LJPC 115.29 26.00 -1.78 -1.24 -355.86
Eloxx Pharmaceuticals, Inc. ELOX 112.71 0.00 4.45 -2.13 None
Lineage Cell Therapeutics, Inc. LCTX 112.50 3.00 1.06 -1.70 -333.12
Kezar Life Sciences, Inc. KZR 110.40 None 1.79 -2.76 None
Cidara Therapeutics, Inc. CDTX 108.50 23.00 2.67 -2.71 -178.43
Arbutus Biopharma Corp. ABUS 108.00 7.00 -1.86 -0.67 -797.42
Applied Genetic Technologies Corp. AGTC 106.97 3.00 1.71 -2.58 -4.81
Axcella Health, Inc. AXLA 98.67 None 3.27 -1.59 None
22nd Century Group, Inc. XXII 97.65 27.00 1.80 -3.44 -107.21
Recro Pharma, Inc. REPH 97.44 96.00 -7.81 -3.79 -25.38
Orgenesis, Inc. ORGS 92.96 28.00 1.43 1.93 199.32
iBio, Inc. IBIO 92.80 1.00 77.33 -2.39 -884.69
Savara, Inc. SVRA 92.70 0.00 1.23 -1.10 None
AquaBounty Technologies, Inc. AQB 89.24 0.00 3.56 -6.58 None
Axovant Gene Therapies Ltd. AXGT 87.50 None 2.29 -1.19 None
Monopar Therapeutics, Inc. MNPR 87.34 None 6.79 -21.46 None
BioNTech US, Inc. NTGN 85.96 None 3.01 -1.07 None
Unum Therapeutics, Inc. UMRX 85.20 26.00 4.12 -3.34 -99.09
Catabasis Pharmaceuticals, Inc. CATB 84.89 1.00 2.18 -2.93 None
resTORbio, Inc. TORC 81.72 None 1.10 -1.02 None
vTv Therapeutics, Inc. VTVT 78.40 2.00 -2.49 -5.09 -905.13
Windtree Therapeutics, Inc. WINT 78.00 0.00 1.27 -2.72 None
Organovo Holdings, Inc. ONVO 76.70 2.00 2.95 -4.21 -852.00
Vaccinex, Inc. VCNX 76.16 0.00 -3.63 -2.55 None
T2 Biosystems, Inc. TTOO 75.40 9.00 -24.17 -1.23 -646.60
Catalyst Biosciences, Inc. CBIO 72.67 16.00 1.26 -1.54 -269.75
Lumos Pharma, Inc. LUMO 70.95 1.00 0.97 -1.46 -429.65
DiaMedica Therapeutics, Inc. DMAC 70.80 1.00 6.28 -7.28 None
AVEO Pharmaceuticals, Inc. AVEO 66.88 28.00 15.48 83.60 1.62
Sesen Bio, Inc. SESN 66.44 0.00 3.95 -0.85 6.31
Proteostasis Therapeutics, Inc. PTI 64.77 5.00 1.26 -1.19 -460.52
Synlogic, Inc. SYBX 61.71 2.00 0.43 -1.13 None
Anixa Biosciences, Inc. ANIX 59.01 0.00 12.77 -6.11 -14.90
ContraFect Corp. CFRX 59.00 None 19.03 -1.69 None
Actinium Pharmaceuticals, Inc. ATNM 56.63 None 34.74 -2.67 None
Sierra Oncology, Inc. SRRA 54.50 None 0.87 -0.41 None
Idera Pharmaceuticals, Inc. IDRA 51.90 1.00 1.36 -0.74 -236.98
Nabriva Therapeutics Plc NBRV 51.60 7.00 4.55 -0.59 None
Genocea Biosciences, Inc. GNCA 49.25 0.00 4.38 -1.74 -766.21
Leap Therapeutics, Inc. LPTX 47.84 0.00 5.75 -1.19 None
Opiant Pharmaceuticals, Inc. OPNT 46.85 39.00 1.18 4.24 29.58
Infinity Pharmaceuticals, Inc. INFI 46.57 1.00 -20.42 -1.05 -50.81
Heat Biologics, Inc. HTBX 46.02 3.00 3.69 -2.19 -633.68
NeuroBo Pharmaceuticals, Inc. NRBO 45.48 None 16.13 -3.09 None
Outlook Therapeutics, Inc. OTLK 45.12 6.00 -8.29 -1.52 -789.06
Vascular Biogenics Ltd. VBLT 44.28 1.00 1.86 -2.16 -73.12
Merrimack Pharmaceuticals, Inc. MACK 41.86 144.00 2.39 -6.44 -105.18
Soligenix, Inc. SNGX 40.74 4.00 14.92 -2.73 -346.90
Entasis Therapeutics Holdings, Inc. ETTX 40.30 7.00 3.04 -0.89 -659.64
Oragenics, Inc. OGEN 40.25 1.00 8.75 -2.37 -996.00
Curis, Inc. CRIS 39.78 11.00 -1.06 -1.23 -292.03
Zafgen, Inc. ZFGN 36.63 None 0.73 -1.02 None
OncoMed Pharmaceuticals, Inc. OMED 36.48 44.00 0.77 -4.57 -18.24
Cleveland BioLabs, Inc. CBLI 35.97 1.00 -9.91 -16.35 -220.48
NanoViricides, Inc. NNVC 35.45 None 4.49 -2.30 None
Armata Pharmaceuticals, Inc. ARMP 34.83 0.00 2.15 -1.73 -167.17
Acorda Therapeutics, Inc. ACOR 33.60 176.00 0.11 -0.14 -131.45
Bellicum Pharmaceuticals, Inc. BLCM 32.65 7.00 -4.60 -0.38 -410.63
NovaBay Pharmaceuticals, Inc. NBY 31.68 7.00 -132.00 -4.55 -112.57
Microbot Medical, Inc. MBOT 30.80 0.00 1.47 -4.03 None
Onconova Therapeutics, Inc. ONTX 29.47 2.00 4.63 -2.42 -876.56
Alimera Sciences, Inc. ALIM 29.40 56.00 -0.83 -3.20 -15.97
Miragen Therapeutics, Inc. MGEN 29.22 5.00 1.64 -0.73 -778.69
HTG Molecular Diagnostics, Inc. HTGM 27.64 18.00 1.78 -1.47 -106.35
Seelos Therapeutics, Inc. SEEL 27.00 0.00 6.67 0.76 -128.98
Pulmatrix, Inc. PULM 26.80 11.00 4.96 -1.86 -188.59
Sunesis Pharmaceuticals, Inc. SNSS 26.00 2.00 2.89 -1.18 -749.95
VistaGen Therapeutics, Inc. VTGN 23.74 1.00 -5.39 -1.08 -929.89
Advaxis, Inc. ADXS 22.06 0.00 0.93 -0.27 -79.54
Aptevo Therapeutics, Inc. APVO 21.93 32.00 1.56 -1.37 -78.75
India Globalization Capital, Inc. IGC 21.55 6.00 0.75 -3.17 -102.76
AIM ImmunoTech, Inc. AIM 20.80 0.00 2.48 37.14 None
AzurRx BioPharma, Inc. AZRX 20.45 None 7.44 -1.32 None
Capricor Therapeutics, Inc. CAPR 20.40 1.00 6.09 -2.53 -750.59
9 Meters Biopharma, Inc. NMTR 19.39 2.00 -4.03 -0.71 -468.45
Conatus Pharmaceuticals, Inc. CNAT 18.48 15.00 1.06 -1.87 -68.87
Correvio Pharma Corp. CORV 18.48 33.00 -41.99 -0.53 -107.81
Iterum Therapeutics Plc ITRM 16.95 0.00 -0.48 -0.17 None
aTyr Pharma, Inc. LIFE 15.52 8.00 0.86 -0.92 -185.14
Bio-Path Holdings, Inc. BPTH 14.82 0.00 1.02 -1.52 None
BioCardia, Inc. BCDA 14.76 1.00 -24.60 -1.02 62.28
Cellectar BioSciences, Inc. CLRB 12.69 0.00 8.29 -0.94 None
Diffusion Pharmaceuticals, Inc. DFFN 12.32 0.00 2.93 -0.86 None
SELLAS Life Sciences Group, Inc. SLS 11.16 9.00 2.32 -6.07 -392.81
Rexahn Pharmaceuticals, Inc. REXN 10.88 1.00 1.16 -1.59 -598.19
Aevi Genomic Medicine, Inc. GNMX 10.78 None -4.15 -0.57 None
BioNano Genomics, Inc. BNGO 10.31 9.00 -9.82 -0.32 -345.00
Synthetic Biologics, Inc. SYN 8.34 3.00 -1.69 -0.53 -54.07
Precipio, Inc. PRPO 8.12 4.00 1.51 -0.44 -499.72
ENDRA Life Sciences, Inc. NDRA 8.02 0.00 5.24 -0.39 -538.30
TRACON Pharmaceuticals, Inc. TCON 7.60 3.00 3.73 -0.33 -218.20
ARCA biopharma, Inc. ABIO 6.72 None 2.42 -2.15 None
Achieve Life Sciences, Inc. ACHV 5.60 5.00 1.00 -0.33 -397.65
Achieve Life Sciences, Inc. ACHV 5.60 5.00 1.00 -0.33 -397.65
Ocugen, Inc. OCGN 5.43 0.00 2.87 0.04 None
Plus Therapeutics, Inc. PSTV 4.44 6.00 111.00 6.00 -147.01
Cyclacel Pharmaceuticals, Inc. CYCC 4.36 0.00 2.04 -0.51 -748.10
Xenetic Biosciences, Inc. XBIO 4.00 0.00 0.39 -14.29 -47.40
AIkido Pharma, Inc. AIKI 3.36 0.00 1.40 -0.42 -267.48
Seneca Biopharma, Inc. SNCA 2.92 0.00 1.26 -0.56 None
Tocagen, Inc. TOCA 2.52 0.00 0.96 -0.04 -271.43
Phio Pharmaceuticals Corp. PHIO 2.29 0.00 0.87 -0.15 None
Spherix, Inc. SPEX 1.83 0.00 0.00 -0.37 -267.48
Invivo Therapeutics Holdings Corp. NVIV 1.41 None 0.72 -0.05 None
Sophiris Bio, Inc. SPHS 0.31 5.00 -0.12 -0.04 -222.98
SenesTech, Inc. SNES 0.00 0.00 3.26 -0.01 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease

7d ago, source: YAHOO!

Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines ...

Palatin Reinitiates Enrollment Of Phase 2 Study With PL9643 To Treat Dry Eye Disease

7d ago, source: Nasdaq

(RTTNews) - Biopharmaceutical company Palatin Technologies, Inc. (PTN) announced Wednesday the reinitiation of enrollment of its Phase 2 clinical study with PL9643 for the treatment of dry eye ...

BRIEF-Palatin Technologies Announces Reinitiation Of Enrollment Of Phase 2 Study With Pl9643 For Treatment Of Dry Eye Disease

7d ago, source: Reuters

PALATIN TECHNOLOGIES, INC. ANNOUNCES REINITIATION OF ENROLLMENT OF PHASE 2 STUDY WITH PL9643 FOR THE TREATMENT OF DRY EYE DISEASE * ...

Palatin Reinitiates Enrollment Of Phase 2 Study With PL9643 To Treat Dry Eye Disease

7d ago, source: Business Insider

Biopharmaceutical company Palatin Technologies, Inc. (PTN) announced Wednesday the reinitiation of enrollment of its Phase 2 clinical ...

Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease

7d ago, source: Business Insider

© 2020 Insider Inc. and finanzen.net GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease

7d ago, source: WFMZ-TV

Palatin Technologies, Inc. is a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide ...

BRIEF-Palatin Technologies Announces Reinitiation Of Enrollment Of Phase 2 Study With Pl9643 For Treatment Of Dry Eye Disease

7d ago, source: Reuters

PALATIN TECHNOLOGIES INC - DATA READOUT TARGETED FOR Q4 OF CALENDAR YEAR 2020 * PALATIN TECHNOLOGIES - PATIENT ENROLLMENT FOR PL9643 PHASE 2 CLINICAL STUDY IS CURRENTLY EXPECTED TO BE COMPLETE ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.